Key result
Portable insulin pumps reduce mean blood glucose ~47% vs conventional therapy in unstable diabetes.
Why the study?
The long-term feasibility and comparative effectiveness of insulin infusion via portable pumps through subcutaneous, intravenous, and intraperitoneal routes in severely unstable diabetic individuals were unclear.
Does intraperitoneal insulin infusion via portable pumps improve diabetic control and long-term feasibility compared to subcutaneous or intravenous routes in severely unstable diabetic individuals?
RCT (n=6)
randomized
Does intraperitoneal insulin infusion via portable pumps improve diabetic control and long-term feasibility compared to subcutaneous or intravenous routes in severely unstable diabetic individuals?
Intraperitoneal insulin infusion via portable pumps provides sustained improvement in glycemic control for brittle diabetes and appears more feasible long-term than subcutaneous or intravenous routes due to fewer catheter complications.
Answers are grounded in this paper and cite their sources.
May support implanted catheter pumps in select unstable diabetes; leaves open randomized confirmation of safety and efficacy.
This work compares different routes of insulin infusion via portable pumps with chronically implanted catheters and evaluates the long-term feasibility of the technique. Six severely unstable (i.e., uncontrolled by optimized intensive insulin therapy) diabetic individuals (age range: 35 +/- 4 yr; duration: 11 +/- 2 yr) were selected. Promedos pumps (Siemens A. G., Erlangen, West Germany) were exclusively used because of their portability and long-life insulin reservoir (1-mo duration with U40 acidic Hoechst insulin). Each patient underwent three randomized 1-mo periods of insulin infusion: subcutaneous (s.c.), intravenous (i.v.), and intraperitoneal (i.p.) before the catheter was left indefinitely in one of these sites. Diabetic control was improved and insulin doses reduced whatever the route of infusion, although the s.c. route gave slightly higher values. These results did not deteriorate with time: mean blood glucose was 126 +/- 3 mg/dl and HbA1 was 8.3 +/- 0.6% after 10-18 mo of constant infusion versus 237 +/- 35 mg/dl and 10.0 +/- 0.8%, respectively, under conventional therapy. From a practical point of view, the i.p. route seems preferable since all s.c. catheters provoked local reactions after less than 1 mo and the two chronic i.v. catheters obstructed after 8 and 9 mo. All other incidents were minor and curable without removal of the catheters. All patients argued improvement of both diabetes and quality of life and no one has resigned so far. Thus, the i.p. infusion technique seems beneficial to unstable diabetic individuals and adaptable to long-term therapy, although intensive education and careful follow-up are necessary.
No takes yet. Share an insight, caveat, or question.
Sélam et al. (1983) conducted an RCT in Brittle Diabetes (n=6). Constant insulin infusion via portable pumps vs. Conventional therapy was evaluated on Mean blood glucose (mg/dl). Long-term constant insulin infusion via portable pumps improved mean blood glucose and HbA1 compared to conventional therapy in unstable diabetic individuals.
Synapse has enriched 10 related papers. Consider them for comparative context: